In order to demonstrate its functionality in optimizing population dichotomization with known or candidate biomarkers, we used CoxPH SubID to validate the previously reported relationship between INPP4B expression levels and patient outcome in AML. The gene discussed is INPP4B; the disease is acute myeloid leukemia.